Search results
Eli Lilly’s Alzheimer’s drug to face safety, dosing scrutiny from FDA advisers
Market Watch· 24 hours agoThere...the document. Among the key safety considerations, the FDA said in its report, are...
The Potential Benefits and Dangers of Rewiring the Brain
Mercola· 6 hours agoThe panel includes neuroscientists Takao Hensch and John Krakauer, as well as entrepreneur Brett Wingeier, co-founder and CEO of Magnus Medical. This capacity could potentially heal depression ...
'Chameleon' attacks drug-resistant brain cancers
Futurity· 2 days agoIn a new study, researchers describe how a novel chemical compound attacks drug-resistant brain tumors without harming healthy surrounding tissue. The research ...
Sleep and Social Media Impact Youth Brain Development
Medscape· 4 days agoA study of teens revealed distinct interactions between sleep duration, social media use, and brain...
Lifestyle Changes May Slow or Prevent Alzheimer’s in People at High Risk | FOX 28 Spokane
FOX 28 Spokane· 1 day agoNew research shows that a set of healthy lifestyle habits can help preserve brain function in folks...
Children with autism have more gray matter in brain's outer layer than others
UPI· 16 hours agoToddlers with autism have cerebral cortexes -- often referred to as "gray matter" -- that are...
Scientists pinpoint likely origin of stuttering in the brain
Live Science via Yahoo News· 2 days agoThe brain imaging results were described in a recent paper, published May 27 in the journal Brain....
Researchers create 'chameleon' compound that targets drug-resistant brain cancers
Medical Xpress· 5 days agoThe research, published in the Journal of the American Chemical Society, is a crucial step in the development of so-called "chameleon compounds" that may be used to target ...
Acid for the ear
Politico· 19 hours agoThe agency has awarded $825,000 to Boston-based Delix Therapeutics for the development of a nonhallucinogenic version of the famed counterculture drug...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 7 days agoResults from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity and duration of treatment Initial data from Phase 0/1 “trigger” (“window of
